Specialty Focused Recordings: Neuro-Oncology-Perioperative Pituitary Tumor Resection

Video Transcription

Video Summary

The presentation described a multidisciplinary guideline for recognizing and managing neuroendocrine complications after adult endoscopic pituitary tumor resection. Its goals are to standardize care while allowing clinicians to individualize treatment, and to ensure staff across the PACU, ICU, and step-down units can identify complications promptly.<br /><br />The main conditions discussed were central diabetes insipidus (DI), SIADH, and panhypopituitarism. DI may be transient, and patients with an intact thirst mechanism and access to water may compensate without medication. The guideline diagnoses DI using increased urine output, urine specific gravity below 1.005, and serum sodium above 145; monitoring also includes fluid balance, vital signs, weights, and serial laboratory tests. Treatment depends on whether the patient can keep up with fluid losses; desmopressin may be used when intervention is needed. Because patients can shift between DI and SIADH, cautious treatment and continued monitoring are essential. The talk also emphasized considering pre-existing endocrine dysfunction and intraoperative mannitol when interpreting postoperative urine output.

Keywords

endoscopic pituitary tumor resection

neuroendocrine complications

central diabetes insipidus

SIADH

panhypopituitarism

desmopressin